Teva CEO Says Not Too Late to Launch Humira Biosimilar in 2024 ...Middle East

Medscape - News
Teva will still pursue launching a biosimilar of AbbVie's blockbuster arthritis drug Humira next year despite a crowded marketplace, Chief Executive Richard Francis said on Wednesday. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( Teva CEO Says Not Too Late to Launch Humira Biosimilar in 2024 )

Apple Storegoogle play

Also on site :